Back
Legend Biotech Corporation (LEGN)
BiotechnologyLEGN · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$27.38
−1.76%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$-0.81
ROE
-25.2%
Gross margin
55.0%
Debt/Equity
0.40x
Revenue growth
56.5%
Legend Biotech Corporation — company intelligence
Earnings surprises
Q1 2026$-0.30 vs $-0.02 est-1295.3%
Q4 2025$-0.16 vs $-0.11 est-44.5%
Q3 2025$-0.22 vs $-0.09 est-155.5%
Q2 2025$-0.68 vs $-0.15 est-366.1%
Analyst consensus · 22 analysts
19 Buy3 Hold0 Sell
Updated Jul 7, 2026
Recent SEC filings
4 — Insider transaction reportJul 2, 2026
4 — Insider transaction reportJul 2, 2026
4 — Insider transaction reportJun 29, 2026
Latest news
RBC Capital Maintains Outperform on Legend Biotech, Lowers Price Target to $63 — Benzinga · 3d ago
Why Is Legend Biotech Stock Falling Thursday? — Benzinga · 3w ago
Legend Biotech, Sleep Number And Other Big Stocks Moving Lower In Thursday's Pre-Market Session — Benzinga · 3w ago
Why Smith & Wesson Brands Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket — Benzinga · 3w ago
Legend Biotech Commences $225M Offering Of Its American Depositary Shares — Benzinga · 3w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Legend Biotech Corporation
Weekly undervalued picks (like LEGN)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.